Expertise in
10
conditions

Dr. Milan J. Anadkat

Dermatology
Washington University
1 Barnes Jewish Hospital Plz, 
Saint Louis, MO 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Expertise in
10
conditions
Washington University
1 Barnes Jewish Hospital Plz, 
Saint Louis, MO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Milan Anadkat is a Dermatologist in Saint Louis, Missouri. Dr. Anadkat is highly rated in 10 conditions, according to our data. His top areas of expertise are Generalized Pustular Psoriasis (GPP), Pustular Psoriasis, Pustules, and Hidradenitis Suppurativa. Dr. Anadkat is currently accepting new patients.

His clinical research consists of co-authoring 72 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Dermatology
Licenses
Dermatology in MO
Hospital Affiliations
Barnes Jewish Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Home State Health
  • EPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

WASHINGTON UNIVERSITY
1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110
Other Locations
WASHINGTON UNIVERSITY
969 N Mason Rd, Barnes Jewish W County Der, St Louis, MO 63141
WASHINGTON UNIVERSITY
4901 Forest Park Ave, Saint Louis, MO 63108

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Analysis of Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease
Analysis of Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease
Enrollment Status: Recruiting
Publish Date: March 13, 2025
Intervention Type: Procedure
A Pragmatic Trial of Home Versus Office Based Narrow Band Ultraviolet B Phototherapy for the Treatment of Psoriasis
A Pragmatic Trial of Home Versus Office Based Narrow Band Ultraviolet B Phototherapy for the Treatment of Psoriasis
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Phase II Study to Evaluate the Safety and Efficacy of OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients
A Phase II Study to Evaluate the Safety and Efficacy of OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients
Enrollment Status: Unknown
Publish Date: March 04, 2024
Intervention Type: Drug
Study Phase: Phase 2
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
Enrollment Status: Completed
Publish Date: November 07, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase 1, Open-Label, Dose Escalation Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy Study of Topically Administered LUT014 in Metastatic Colorectal Cancer Patients With EGFR Inhibitor Induced Acneiform Lesions
A Phase 1, Open-Label, Dose Escalation Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy Study of Topically Administered LUT014 in Metastatic Colorectal Cancer Patients With EGFR Inhibitor Induced Acneiform Lesions
Enrollment Status: Completed
Publish Date: April 06, 2022
Intervention Type: Drug
Study Phase: Phase 1
Phase IB Pilot Study of Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer
Phase IB Pilot Study of Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer
Enrollment Status: Terminated
Publish Date: June 21, 2021
Intervention Type: Drug, Device, Procedure, Other
Study Phase: Phase 1
View 5 Less Clinical Trials

72 Total Publications

Targeting the IL-36 receptor with spesolimab mitigates residual inflammation and prevents generalized pustular psoriasis flares.
Targeting the IL-36 receptor with spesolimab mitigates residual inflammation and prevents generalized pustular psoriasis flares.
Journal: The Journal of clinical investigation
Published: July 01, 2025
Similar Doctors
Expertise in
8
conditions
Dr. Amy C. Musiek
Dermatology
Expertise in
8
conditions
Dr. Amy C. Musiek
Dermatology

Washington University

4901 Forest Park Ave, 
Saint Louis, MO 
 (0.3 miles away)
314-362-5060
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Amy Musiek is a Dermatologist in Saint Louis, Missouri. Dr. Musiek is highly rated in 8 conditions, according to our data. Her top areas of expertise are Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, T-Cell Lymphoma, Sezary Syndrome, and Bone Marrow Aspiration. Dr. Musiek is currently accepting new patients.

Expertise in
8
conditions
Dr. Elaine C. Siegfried
Dermatology | Pediatrics
Expertise in
8
conditions
Dr. Elaine C. Siegfried
Dermatology | Pediatrics

Ssm Health Care Group

10101 Woodfield Ln, 
Saint Louis, MO 
 (7.9 miles away)
608-280-4647
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients

Elaine Siegfried is a Dermatologist and a Pediatrics provider in Saint Louis, Missouri. Dr. Siegfried is highly rated in 8 conditions, according to our data. Her top areas of expertise are Atopic Dermatitis, Molluscum Contagiosum, Aplasia Cutis Congenita, and Clouston Syndrome. Dr. Siegfried is currently accepting new patients.

Expertise in
52
conditions
Dr. James W. Donnelly
Dermatology
Expertise in
52
conditions
Dr. James W. Donnelly
Dermatology

Associates In Dermatology And Cutaneous Surgery Ltd

222 S Woods Mill Rd, Suite 710n, 
Chesterfield, MO 
 (12.9 miles away)
314-576-1411
Languages Spoken:
English
See accepted insurances

James Donnelly is a Dermatologist in Chesterfield, Missouri. Dr. Donnelly is highly rated in 52 conditions, according to our data. His top areas of expertise are Seborrheic Keratosis, Warts, Actinic Keratosis, and Neurocutaneous Melanosis.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Anadkat's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 51 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile